KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Discontinued OperationsCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Share-based Compensation (2016 - 2025)

LifeMD (LFMD) has disclosed Share-based Compensation for 14 consecutive years, with -$4.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Share-based Compensation fell 271.58% year-over-year to -$4.1 million, compared with a TTM value of $535000.0 through Dec 2025, down 95.63%, and an annual FY2025 reading of $535000.0, down 95.63% over the prior year.
  • Share-based Compensation was -$4.1 million for Q3 2025 at LifeMD, down from $2.1 million in the prior quarter.
  • Across five years, Share-based Compensation topped out at $4.5 million in Q1 2022 and bottomed at -$4.1 million in Q3 2025.
  • Average Share-based Compensation over 5 years is $2.7 million, with a median of $2.8 million recorded in 2023.
  • The sharpest move saw Share-based Compensation soared 4296.54% in 2021, then plummeted 271.58% in 2025.
  • Year by year, Share-based Compensation stood at $4.1 million in 2021, then plummeted by 53.9% to $1.9 million in 2022, then skyrocketed by 93.44% to $3.6 million in 2023, then dropped by 14.83% to $3.1 million in 2024, then crashed by 232.31% to -$4.1 million in 2025.
  • Business Quant data shows Share-based Compensation for LFMD at -$4.1 million in Q3 2025, $2.1 million in Q2 2025, and $2.5 million in Q1 2025.